Advertisement
Financing › Details
Bind-X–K&K 1: investment, 202308 financing round Series B totalling €10m incl new investor K&K 1
Period | 2023-08-01 | |
Money taker | Bind-X GmbH | |
Group | Bind-X (Group) | |
Money source | K&K 1 | |
Product | Bind-Tech® technology platform | |
Product 2 | venture capital | |
Index term | Bind-X–SEVERAL: investment, 202308 financing round Series B €10m with HG Ventures + K&K1 + Greeneering Invest + Saxovent | |
High-Tech Gründerfonds Management GmbH. (8/1/23). "Press Release: Bind-X Secures €10 Million in Financing as Part of Its Series B Financing Round". Martinsried.
Specialist in biological binding of materials expands internationally and prepares further market entries in agriculture, mining, and infrastructure.
Bind-X, a fast-growing industrial biotechnology company, has successfully closed a €10 million financing round. The funding was provided by renowned investors from Germany and abroad (HG Ventures, K&K 1, Greeneering Invest, Saxovent) and will help drive the decarbonization and biologization of established industries.
Bind-X’s further growth will focus on products for alternative weed control in agriculture, biological dust suppression in the mining industry, and the reduction of the use of bitumen in road construction.
“We are pleased to partner with Bind-X on their unique industrial biotechnology platform. We look forward to backing this team of experts to support this critical area of innovation and explore new product applications.”
John Glushik, Managing Director of HG Ventures, the corporate venture arm of Heritage Group, headquartered in Indianapolis, USA
The latest investment round demonstrates investors’ continued confidence in Bind-X’s versatile technology platform, Bind-Tech®, and its pioneering commitment to making entire industries more sustainable and efficient. The company’s goal is to save its customers megatons of CO2 emissions through innovative binders.
“Our new shareholders are an ideal complement to the existing consortium. Their relevant industry experience will further increase the current momentum and lead to strong growth in our core markets.”
Kay Balster, Principal at High-Tech Gründerfonds
“We are thrilled about the strong interest in our Series B financing round and grateful for the trust our existing shareholders, HTGF and Vantage Value, and new investors place in Bind-X. This financing will allow us to continue our global expansion, increase production capacity, and expand our team further at three international locations.”
Martin Spitznagel, founder and CEO of Bind-X
[photo]
Bind-X Board (from left): Dr. Luitpold Fried, CTO; Dr. Martin Krehenbrink, CPO; Martin Spitznagel, CEO and Heinz Schwan, CFO (not in the photo)
About Bind-X
Bind-X is an industrial biotechnology company based in Martinsried near Munich. Its mission is to increase the sustainability of established industries through the use of biobased products. Bind-X’s broad product portfolio includes innovative solutions for various industries and is based on the multi-patented technology platform Bind-Tech®. Currently, a multi-disciplinary team at three locations is working towards the goal of transforming the global agriculture, mining, and infrastructure sectors, thereby making a tangible contribution to a sustainable future today. In line with the company´s slogan: Turn solid into impact!
www.bind-x.com
Press contact: +49 89 2620 344 40, press@bind-x.com
About HG Ventures
HG Ventures is the corporate venture arm of The Heritage Group, headquartered in Indianapolis, Indiana, USA. HG Ventures supports innovation and growth across The Heritage Group by investing and partnering with innovative, high-growth companies to support a sustainable future. The firm leverages the world-class expertise of The Heritage Group operating companies and research center to offer a unique value proposition to its portfolio company partners.
www.hgventures.com
About Saxovent Smart Eco Investments
Saxovent Smart Eco Investments (Home – Saxovent) is a Berlin based project developer in the areas of wind, solar, real estate and an active impact investor in the agricultural-technology space. The founder led company has since 1997 been supporting technologies to combat climate change with the goal to leave the planet habitable for future generations.
About Vantage Value
Vantage Value is a family office with a focus on investments in biotech, medtech, robotics and software.
About High-Tech Gründerfonds
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise, entrepreneurial spirit, and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. To date, external investors have injected more than 4.5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies.
Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital, and 45 companies from a wide range of industries.
Kay G. Balster – Principal / Authorized signatory
Record changed: 2024-01-09 |
Advertisement
More documents for Bind-X (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top